The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O(2)max Depends on the Severity of Arterial Hypoxemia

Treatment with recombinant human erythropoietin (rhEpo) induces a rise in blood oxygen-carrying capacity (CaO(2)) that unequivocally enhances maximal oxygen uptake (V̇O(2)max) during exercise in normoxia, but not when exercise is carried out in severe acute hypoxia. This implies that there should be...

Descripción completa

Detalles Bibliográficos
Autores principales: Robach, Paul, Calbet, Jose A. L., Thomsen, Jonas J., Boushel, Robert, Mollard, Pascal, Rasmussen, Peter, Lundby, Carsten
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500186/
https://www.ncbi.nlm.nih.gov/pubmed/18714372
http://dx.doi.org/10.1371/journal.pone.0002996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500186/
https://www.ncbi.nlm.nih.gov/pubmed/18714372
http://dx.doi.org/10.1371/journal.pone.0002996

Ejemplares similares